Specifically, lower CAN functional connectivity is associated with decreased plasma Aβ<sub>42/40</sub>, indicative of cerebral amyloidosis, and increased plasma GFAP in APOE4 carriers at risk for AD. The gene discussed is GFAP; the disease is Alzheimer disease.